VKTX · ISSUER CIK 1607678
Viking Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Viking Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 7, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 202616:34 | Aug 1, 2026 | VKTX | Director | A · GrantLate 6d | — | +6,333 | 6,333 | New | — |